GRAIL has announced that it is joining forces with AccessHope™ to offer a world-class service experience to people who use Galleri™, GRAIL’s first-of-kind multi-cancer early detection blood test. This collaboration is part of GRAIL’s effort to help patients and their healthcare providers achieve favorable outcomes...
The use of wearables has been of great benefit to clinical trials: researchers can gather far more data, more often, more objectively, and more easily than ever before. And over the past year, digital tools for remote measurement made it possible to continue trials that...
GRAIL today announced a partnership with the health system Providence to offer Galleri, GRAIL’s multi-cancer early detection blood test. Providence, based in Renton, Wash., will offer Galleri as a complement to recommended single cancer screening tests. Providence will initially deploy Galleri at its California, Washington, and...
GRAIL has entered an agreement with Quest Diagnostics to provide phlebotomy services in support of its multi-cancer early detection blood test. The test, called Galleri, is expected to go to market in the second quarter after its PATHFINDER multi-site interventional study. Under the agreement, Quest’s phlebotomy network,...
Truveris, a digital health company focused on reducing costs and improving access in pharmacy, announced that it has bolstered its leadership team with several key hires and internal appointments. Under the leadership of CEO Jeff Eberle, Truveris has assembled a seasoned team of industry veterans...
Hims launched in 2017 as a men’s health company, selling just a few products designed to help men suffering from erectile dysfunction or hair loss. Now the company has expanded greatly, adding a women’s health business called Hers, focused on birth control, sexual health, and...
Hims & Hers Health Inc (“Hims & Hers”), a multi-specialty telehealth platform, announced that it has closed its business combination with Oaktree Acquisition Corp., a special purpose acquisition company sponsored by an affiliate of Oaktree Capital Management. The transaction, which was approved by Oaktree’s shareholders...
Aledade recently closed a $100 million Series D funding round following a year of significant growth for its national network of risk-taking primary care practices. Returning investor Meritech Capital led the round, which included new growth investors Tiger Global Management and IVP, and returning investor...
Kyruus announced that it has expanded its patient access platform to enable customers to offer online consumer scheduling for COVID-19 vaccine visits. The vaccine scheduling capabilities are available within the company’s award-winning online scheduling solution. Almost 10 health systems have already activated vaccine scheduling with Kyruus,...
On a recent episode of the Moneyball Medicine podcast, host Harry Glorikian interviewed Evidation Co-CEO Chrstine Lemke on what Evidation does, its history, and how its work has evolved since the company started. Smart devices like Fitbits and Apple Watches are with us all the time,...